SAN
DIEGO, July 8, 2024 /PRNewswire/ -- Aspen
Neuroscience, Inc. a clinical-stage private biotechnology company
developing personalized regenerative therapies, announced today
that president and CEO Damien
McDevitt, PhD, will participate in a virtual fireside chat
at the Stifel 2024 Virtual Cell Therapy
Forum this Tuesday, July 9 at 10:35am PT
(1:35pm ET).
Aspen Neuroscience President and CEO
Damien McDevitt, PhD, will
participate in a virtual fireside chat
A live webcast of the fireside chat will be broadcast during the
event. Viewers can watch the live webcast at
https://wsw.com/webcast/stifel94/aspns/2289060.
About Aspen Neuroscience
Headquartered in San Diego, Aspen
Neuroscience, Inc. is focused on autologous regenerative medicine.
The company's patient-derived induced pluripotent stem cell (iPSC)
platform is used to create personalized therapies to address
diseases with high unmet medical needs, beginning with autologous
neuron replacement for Parkinson's disease.
Aspen combines stem cell biology with the latest machine
learning and genomic approaches to investigate patient-specific,
restorative cell treatments. The company has developed a
best-in-class platform to create and optimize iPSC-derived cell
therapies. The platform includes in-house bioinformatics,
manufacturing and quality control. For more information and
important updates, please
visit https://www.aspenneuroscience.com.
View original
content:https://www.prnewswire.com/news-releases/aspen-neuroscience-to-present-at-stifel-2024-cell-therapy-forum-july-9-302190509.html
SOURCE Aspen Neuroscience, Inc.